David W. Haas, MD
Vanderbilt University School of Medicine
345 24 Avenue North
Nashville,
TN
USA
Papers:
TRA-2-1
COST-EFFECTIVENESS ANALYSIS OF CYP2B6 GENETIC TESTING TO INFORM EFAVIRENZ DOSE REDUCTION FOR INITIAL HIV THERAPY
Student?
yes
SMDM Member?
yes